C. Gutiérrez-Aguirre

发表

Current state and perspectives of stem cell therapy for stroke

D. Gómez-Almaguer, O. Cantú-Rodríguez, J. Jaime-Pérez, 2016 .

Measurements of Catheter, Venous, and Capillary Cyclosporine A Blood Are Comparable and Useful in Pediatric Hematopoietic Stem Cell Transplant Recipients

L. Villarreal-Martínez, D. Gómez-Almaguer, J. Jaime-Pérez, 2017, Acta Haematologica.

Lower than expected cytogenetic and molecular response to imatinib in Mexican patients with chronic myelogenous leukemia

R. Ortíz-López, D. Gómez-Almaguer, J. Jaime-Pérez, 2013, Hematology.

Age Acts as an Adverse Independent Variable for Survival in Acute Lymphoblastic Leukemia: Data From a Cohort in Northeast Mexico

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2017, Clinical lymphoma, myeloma & leukemia.

Outcomes of Adolescents and Young Adults With Acute Myeloid Leukemia Treated in a Single Latin American Center

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2018, Clinical lymphoma, myeloma & leukemia.

Coronavirus disease-19 in Hematology. The perspective of a middle-income country

D. Gómez-Almaguer, O. Cantú-Rodríguez, J. Jaime-Pérez, 2020, Revista Medicina Universitaria.

Danazol as First‐Line Therapy for Myelodysplastic Syndrome

E. Rendón-Ramírez, D. Gómez-Almaguer, J. Jaime-Pérez, 2017, Clinical lymphoma, myeloma & leukemia.

A multicenter, open-label, noncomparative screening study of enzastaurin in adult patients with non-Hodgkin lymphomas.

O. Hamid, D. Gómez-Almaguer, Neil V. Smith, 2013, Clinical lymphoma, myeloma & leukemia.

Long-Term Insulin Independence in Type 1 Diabetes Mellitus Using a Simplified Autologous Stem Cell Transplant.

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2016, The Journal of clinical endocrinology and metabolism.

Efficacy of mitoxantrone as frontline anthracycline during induction therapy in adults with newly diagnosed acute lymphoblastic leukemia: a single-center experience

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2015, Leukemia & lymphoma.

Secondary malignancies after allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning and outpatient conduction

G. Ruiz-Argüelles, D. Gómez-Almaguer, C. Gutiérrez-Aguirre, 2014, Hematology.

RIC___Vol 72___Num 02___March-April 2020___ABRIL'20___V09.indd

D. Gómez-Almaguer, O. Cantú-Rodríguez, J. Jaime-Pérez, 2020 .

IMPACT OF HLA-DPB1 MATCHING ON CLINICAL OUTCOMES AFTER HAPLOIDENTICAL-RELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION.

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2020, Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion.

Non-myeloablative hematopoietic stem cell transplantation is of limited value in advanced or refractory acute myeloblastic leukemia. The Mexican experience

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2007, Hematology.

Outpatient haploidentical hematopoietic stem cell transplant using post-transplant cyclophosphamide and incidence of hemorrhagic cystitis

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2020, Hematology, transfusion and cell therapy.

Safety and Cost-Effectiveness of a Simplified Method for Lumbar Puncture in Patients with Hematologic Malignancies

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2014, Acta Haematologica.

Combination of low-dose imatinib plus nilotinib for the treatment of chronic-phase chronic myeloid leukaemia after imatinib failure

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2016, Hematology.

The treatment of CML at an environment with limited resources

G. Ruiz-Argüelles, D. Gómez-Almaguer, O. Cantú-Rodríguez, 2016, Hematology.

Comparative analysis of iron status and other hematological parameters in preeclampsia†

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2017, Hematology.

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias.

Manuel Solano-Genesta, D. Gómez-Almaguer, J. Jaime-Pérez, 2010, Blood.

High response rate to low‐dose rituximab plus high‐dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2013, European journal of haematology.

Cultural factors related to adherence to imatinib in CML: A Mexican perspective

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2015, Hematology.

The prognostic significance of serum XCL1 concentration in patients with acute lymphoblastic leukemia: a pilot study

D. Gómez-Almaguer, J. Jaime-Pérez, A. Rosas-Taraco, 2017, Annals of Hematology.

Autologous peripheral blood stem cell transplantation in multiple myeloma using oral versus I.V. melphalan

J. Vela-Ojeda, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2007, Annals of Hematology.

Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?

S. Giralt, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2008, Bone Marrow Transplantation.

Non-myeloablative stem cell transplantation in patients with relapsed acute lymphoblastic leukemia: results of a multicenter study

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2007, Bone Marrow Transplantation.

Moderate hyperprolactinemia is associated with survival in patients with acute graft-versus-host disease after allogeneic stem cell transplantation

G. Ruiz-Argüelles, D. Gómez-Almaguer, C. Gutiérrez-Aguirre, 2012, Hematology.

Autologous ATG-free hematopoietic stem cell transplantation for refractory autoimmune rheumatic diseases: a Latin American cohort

D. Galarza-Delgado, D. Gómez-Almaguer, J. Jaime-Pérez, 2021, Clinical Rheumatology.

Effectiveness of subcutaneous low-dose alemtuzumab and rituximab combination therapy for steroid-resistant chronic graft-versus-host disease

Manuel Solano-Genesta, D. Gómez-Almaguer, J. Jaime-Pérez, 2012, Haematologica.

Impact of outpatient non-myeloablative haematopoietic stem cell transplantation in quality of life vs. conventional therapy

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2016, Psychology, health & medicine.

Low incidence and severity of graft‐versus‐host disease after outpatient allogeneic peripheral blood stem cell transplantation employing a reduced‐intensity conditioning

G. Ruiz-Argüelles, D. Gómez-Almaguer, J. Jaime-Pérez, 2011, European journal of haematology.

Danazol as first-line therapy for aplastic anemia

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2011, Annals of Hematology.

Outpatient transplantation in the COVID-19 era: a single-center Latin American experience

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2021, Bone Marrow Transplantation.

Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine‐based conditioning regimen: The Mexican experience

J. Vela-Ojeda, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2006 .

Allografting in patients with severe, refractory aplastic anemia using peripheral blood stem cells and a fludarabine-based conditioning regimen: the Mexican experience.

J. Vela-Ojeda, G. Ruiz-Argüelles, D. Gómez-Almaguer, 2005, American journal of hematology.

Outpatient allogeneic hematopoietic stem-cell transplantation: a review

D. Gómez-Almaguer, O. Cantú-Rodríguez, C. Gutiérrez-Aguirre, 2022, Therapeutic advances in hematology.

Assessing the efficacy of an ambulatory peripheral blood hematopoietic stem cell transplant program using reduced intensity conditioning in a low-middle-income country

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2018, Bone Marrow Transplantation.

Cyclosporine A for the Prevention of Ocular Graft versus Host Disease in Allogeneic Hematopoietic Stem Cell Transplant Recipients Is Safe and Feasible

D. Gómez-Almaguer, J. Jaime-Pérez, David Mauricio Martínez-Garza, 2019, Acta Haematologica.

No clinically relevant differences between capillary and venous blood cell counts in adult haematological patients using a nonautomated lancet

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2015, International journal of laboratory hematology.

Eltrombopag and high-dose dexamethasone as frontline treatment of newly diagnosed immune thrombocytopenia in adults.

D. Gómez-Almaguer, J. Jaime-Pérez, C. Gutiérrez-Aguirre, 2014, Blood.

newly diagnosed immune thrombocytopenia in adults Eltrombopag and high-dose dexamethasone as frontline treatment of

G. Ruiz-Argüelles, D. Gómez-Almaguer, O. Cantú-Rodríguez, 2014 .